PTC Therapeutics | Bénéfice Avant Impôts



Pre Tax Profit Changement Date
Acadia Pharmaceuticals USD 161.08M 122.28M 2024-12
Alnylam Pharmaceuticals USD -193958000 85.3M 2024-12
Amgen USD 3.38B 111M 2024-12
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Cytokinetics USD -150020000 10.52M 2024-12
Daiichi Sankyo JPY 82.41B 26M 2024-12
Gilead Sciences USD 2.96B 112M 2024-12
Incyte USD 406.83M 147.12M 2024-12
Ionis Pharmaceuticals USD -107000000 37M 2024-12
Ironwood Pharmaceuticals USD 17.37M 4.14M 2024-09
Novartis USD 4.66B 269M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
PTC Therapeutics USD -97991000 12.26M 2024-09
Roche Holding CHF 1.78B 2.33B 2024-12
Sarepta Therapeutics USD 171.74M 137.74M 2024-12
TG Therapeutics USD 25.45M 21.18M 2024-12
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12
Xencor USD -52626000 6.33M 2024-12



PTC Therapeutics Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.